Background: To study the health and efficiency of the more up to date oral hypoglycemic specialist sitagliptin in the executives of sort 2 diabetes mellitus patients. In our examination authors have enlisted 250 patients who met our investigation criteria of which authors ordered dependent on age and lab information, most of patients in the age bunch between 45-55 years (n=97, 39.2%), the RBS was diminished to Comparatively estimations of RBS, FBS, PPBS, HbA1C were decreased in follow up than benchmark esteem.Methods: This simultaneous observational investigation was done when all is said in done department of General Medicine of Hi-Tech Medical College and Hospital, Bhubaneswar, Odisha for a time of 6 months in which type 2 diabetes mellitus patients were enrolled dependent on incorporation and avoidance criteria and were pursued to assess the adequacy and security of sitagliptin. Information was dissected by utilizing chart cushion crystal understudy T-test.Results: Authors can presume that sitagliptin use was not related with any dangers and is compelling in the board of Type 2 diabetics, treatment with sitagliptin gave clinically significant decreases in HbA1C, RBS, FBS, PPBS by utilizing this investigation authors realize that gliptins are considerably more protected and powerful in the treatment of sort 2 diabetes mellitus.Conclusion: Treatment with sitagliptin provided clinically meaningful reductions in HbA1C, RBS, FBS, PPBS by using this study authors know that sitagliptins are much more safe and effective in the treatment of type 2 diabetes mellitus.
Safety and Effective Management of Type-2 Diabetes Mellitus Patients by using Sitagliptin
